Infectious Disease Diagnosis & Treatment companies lead the charge against global health threats. Specializing in research, development, and distribution, they provide advanced solutions for accurate diagnosis and effective treatment, contributing to the ongoing battle against infectious diseases.
Thermo Fisher Scientific expands its rapid molecular testing for respiratory infections: Their TaqPath Influenza A/B/RSV & SARS-CoV-2 Multiplex Assay received Emergency Use Authorization (EUA) from the FDA, offering simultaneous testing for common respiratory viruses.
Abbott partners with Gavi to distribute its Strep A test in low- and middle-income countries: This collaboration aims to improve access to early diagnosis and treatment for streptococcal infections.
Roche launches Elecsys® IL-6 test for early identification of sepsis: This new test helps distinguish sepsis from other inflammatory conditions, potentially leading to faster and more targeted treatment.
Merck & Co. announces positive Phase 3 results for its investigational oral antiviral for COVID-19: Molnupiravir, if approved, would offer another treatment option for patients with mild-to-moderate COVID-19.
Novartis receives FDA approval for Zolgensma, a gene therapy for spinal muscular atrophy (SMA): While not directly an infectious disease, Zolgensma represents a significant advancement in gene therapy treatments, with potential applications for other infectious diseases in the future.
List of Infectious Disease Treatment Key companies in the market:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)